In this piece, we will take a look at Ken Fisher’s latest investment portfolio and the 12 biggest positions. If you want to skip our overview of Fisher, his investment firm, and the broader U.S. stock market and macroeconomic environment, then you can take a look at Ken Fisher Portfolio: 5 Biggest Positions. Ken Fisher […]
There's a growing field of competitors in the weight-loss drugs space, where Lilly and Novo currently dominate. Is Eli Lilly stock a buy?
Weight-loss drugs from Novo Nordisk and Eli Lilly lead to massive weight loss. But not all of that weight loss is healthy.